Halo Labs Analysis: $13M Raised

Halo Labs specializes in particle analysis technology for biotherapeutic development. Their innovative approaches, including Backgrounded Membrane Imaging and Fluorescence Membrane Microscopy, enhance the accuracy and speed of particle identification. This technology accelerates decision-making in drug development and manufacturing processes, ensuring safety and quality in biotherapeutics.

Analyze particle contamination in biotherapeutics; Conduct lot release testing for quality control; Assess protein stability and formulation development; Screen viral vector candidates in gene therapy; Ensure cell viability in cell therapy applications.

Recently acquired by Waters Corporation; Focused on compliance with USP 788 standards; Offers innovative solutions for early-stage biotherapeutic development.